GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoform Finland PLC (STU:4YL) » Definitions » Net Interest Income (for Banks)

Nanoform Finland (STU:4YL) Net Interest Income (for Banks)


View and export this data going back to 2020. Start your Free Trial

What is Nanoform Finland Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Nanoform Finland (STU:4YL) Business Description

Industry
Traded in Other Exchanges
Address
Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and by improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications.